Magnus Invention Management Ltd

Where the EU money came from

Funding by EU programme. Amounts are Magnus Invention Management Ltd's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• EVERRESTPartner

  Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  €413ktheir share
• BIOMAGSCARPartner

  Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration

  FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  €601ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Queen Mary University of LondonUnited Kingdom · 2 shared projects
• Ita-Suomen YliopistoFinland · 2 shared projects
• Euram LimitedUnited Kingdom · 2 shared projects
• Trizell LtdUnited Kingdom · 2 shared projects
• University College LondonUnited Kingdom · 1 shared project
• Lunds UniversitetSweden · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Universitaetsklinikum Hamburg-EppendorfGermany · 1 shared project
• Consorci Institut D'Investigacions Biomediques August Pi i SunyerSpain · 1 shared project
• Yale UniversityUnited States · 1 shared project
• University College London Hospitalsnhs Foundation TrustUnited Kingdom · 1 shared project
• Qualimed Innovative Medizinprodukte GmbHGermany · 1 shared project
• Innvotek LtdUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• diabetes
• embryology
• fetal medicine
• gene therapy
• immunotherapy
• nano-materials
• radiology
• vascular diseases